Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
An atypical presentation of Pembrolizumab-induced bullous pemphigoid in a patient with uterine serous carcinoma.
Journal: Gynecologic oncology reports
Published: June 11, 2026
A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor.
Journal: Gynecologic oncology
Published: May 08, 2026
Vaginal Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: March 13, 2026
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: February 11, 2026
Maintenance therapy after first-line therapy for ovarian cancer: Quantitative effectiveness.
Journal: CA: a cancer journal for clinicians
Published: December 09, 2025
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.
Journal: Nature communications
Published: November 05, 2025
Smartphone-Based Measures as Indicators of Functional Status in Patients With Advanced Cancer.
Journal: JAMA network open
Published: September 18, 2025
The impact of romiplostim use for chemotherapy induced thrombocytopenia on immediate and long-term outcomes in gynecologic malignancies.
Journal: Gynecologic oncology
Published: September 18, 2025
Approaches to optimize the benefits of immunotherapy and immunotherapy combinations across endometrial cancer types.
Journal: Journal of the National Cancer Institute
Published: August 13, 2025
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: August 05, 2025
Letrozole, abemaciclib and metformin in endometrial cancer: a non-randomized phase 2 trial.
Journal: Nature communications
Published: July 12, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial Cancer.
Journal: JCO precision oncology
Published: April 10, 2025
Last Updated: 09/26/2026